WO2003004696A3 - A distributed system for epigenetic based prediction of complex phenotypes - Google Patents
A distributed system for epigenetic based prediction of complex phenotypes Download PDFInfo
- Publication number
- WO2003004696A3 WO2003004696A3 PCT/EP2002/006587 EP0206587W WO03004696A3 WO 2003004696 A3 WO2003004696 A3 WO 2003004696A3 EP 0206587 W EP0206587 W EP 0206587W WO 03004696 A3 WO03004696 A3 WO 03004696A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- epigenetic
- distributed system
- based prediction
- phenotypic
- complex phenotypes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003510454A JP2005516269A (en) | 2001-07-02 | 2002-06-14 | A distributed system for predicting complex phenotypes based on epigenetics |
EP02743199A EP1502222A2 (en) | 2001-07-02 | 2002-06-14 | A distributed system for epigenetic based prediction of complex phenotypes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30249001P | 2001-07-02 | 2001-07-02 | |
US60/302,490 | 2001-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003004696A2 WO2003004696A2 (en) | 2003-01-16 |
WO2003004696A3 true WO2003004696A3 (en) | 2004-11-04 |
Family
ID=23167936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/006587 WO2003004696A2 (en) | 2001-07-02 | 2002-06-14 | A distributed system for epigenetic based prediction of complex phenotypes |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030036081A1 (en) |
EP (1) | EP1502222A2 (en) |
JP (1) | JP2005516269A (en) |
WO (1) | WO2003004696A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7805388B2 (en) * | 1998-05-01 | 2010-09-28 | Health Discovery Corporation | Method for feature selection in a support vector machine using feature ranking |
US7318051B2 (en) * | 2001-05-18 | 2008-01-08 | Health Discovery Corporation | Methods for feature selection in a learning machine |
US7475048B2 (en) * | 1998-05-01 | 2009-01-06 | Health Discovery Corporation | Pre-processed feature ranking for a support vector machine |
US7970718B2 (en) * | 2001-05-18 | 2011-06-28 | Health Discovery Corporation | Method for feature selection and for evaluating features identified as significant for classifying data |
EP1268855A2 (en) * | 2000-03-15 | 2003-01-02 | Epigenomics AG | Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
EP1370685A2 (en) * | 2000-04-06 | 2003-12-17 | Epigenomics AG | Diagnosis of diseases associated with dna repair |
AU2001289617A1 (en) * | 2000-06-30 | 2002-01-08 | Epigenomics Ag | Diagnosis of diseases associated with signal transduction |
US7624074B2 (en) * | 2000-08-07 | 2009-11-24 | Health Discovery Corporation | Methods for feature selection in a learning machine |
DE10054974A1 (en) * | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnosis of diseases associated with Cdk4 |
DE10054972A1 (en) * | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnosis of diseases associated with humus |
DE10128508A1 (en) | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Methods and nucleic acids for the differentiation of prostate tumors |
SG120889A1 (en) * | 2001-09-28 | 2006-04-26 | Semiconductor Energy Lab | A light emitting device and electronic apparatus using the same |
US20110151438A9 (en) | 2001-11-19 | 2011-06-23 | Affymetrix, Inc. | Methods of Analysis of Methylation |
JP4367901B2 (en) * | 2003-06-20 | 2009-11-18 | キヤノン株式会社 | Spotter with spot pattern encryption function and detection device that supports spot pattern encryption |
US20060292585A1 (en) * | 2005-06-24 | 2006-12-28 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
US7901882B2 (en) | 2006-03-31 | 2011-03-08 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
WO2008025093A1 (en) * | 2006-09-01 | 2008-03-06 | Innovative Dairy Products Pty Ltd | Whole genome based genetic evaluation and selection process |
US20090049856A1 (en) * | 2007-08-20 | 2009-02-26 | Honeywell International Inc. | Working fluid of a blend of 1,1,1,3,3-pentafluoropane, 1,1,1,2,3,3-hexafluoropropane, and 1,1,1,2-tetrafluoroethane and method and apparatus for using |
US20090094065A1 (en) * | 2007-10-04 | 2009-04-09 | Hyde Roderick A | Systems and methods for underwriting risks utilizing epigenetic information |
US20090094261A1 (en) * | 2007-10-04 | 2009-04-09 | Jung Edward K Y | Systems and methods for correlating epigenetic information with disability data |
US20100027780A1 (en) * | 2007-10-04 | 2010-02-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for anonymizing personally identifiable information associated with epigenetic information |
US20090099877A1 (en) * | 2007-10-11 | 2009-04-16 | Hyde Roderick A | Systems and methods for underwriting risks utilizing epigenetic information |
US20090094281A1 (en) * | 2007-10-04 | 2009-04-09 | Jung Edward K Y | Systems and methods for transferring combined epigenetic information and other information |
US20090094067A1 (en) * | 2007-10-04 | 2009-04-09 | Searete LLC, a limited liability corporation of | Systems and methods for company internal optimization utilizing epigenetic data |
US20090100095A1 (en) * | 2007-10-04 | 2009-04-16 | Jung Edward K Y | Systems and methods for reinsurance utilizing epigenetic information |
US20090094047A1 (en) * | 2007-10-04 | 2009-04-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for predicting a risk utilizing epigenetic data |
JP5838557B2 (en) | 2010-07-05 | 2016-01-06 | ソニー株式会社 | Biological information processing method and apparatus, and recording medium |
JP6222202B2 (en) * | 2010-07-05 | 2017-11-01 | ソニー株式会社 | Biological information processing method and apparatus, and recording medium |
US10635837B1 (en) | 2019-04-30 | 2020-04-28 | HealthBlock, Inc. | Dynamic data protection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214556B1 (en) * | 1997-11-27 | 2001-04-10 | Epigenomics Ag | Method for producing complex DNA methylation fingerprints |
DE10054922A1 (en) * | 1999-11-06 | 2001-05-31 | Dennis Sunga Fernandez | Computerized health service, determines bio-informatic value related to individual genetically-associated risk, and carries out transactions accordingly |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10128508A1 (en) * | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Methods and nucleic acids for the differentiation of prostate tumors |
-
2002
- 2002-06-14 EP EP02743199A patent/EP1502222A2/en not_active Withdrawn
- 2002-06-14 WO PCT/EP2002/006587 patent/WO2003004696A2/en not_active Application Discontinuation
- 2002-06-14 JP JP2003510454A patent/JP2005516269A/en not_active Withdrawn
- 2002-07-01 US US10/186,545 patent/US20030036081A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214556B1 (en) * | 1997-11-27 | 2001-04-10 | Epigenomics Ag | Method for producing complex DNA methylation fingerprints |
DE10054922A1 (en) * | 1999-11-06 | 2001-05-31 | Dennis Sunga Fernandez | Computerized health service, determines bio-informatic value related to individual genetically-associated risk, and carries out transactions accordingly |
Non-Patent Citations (3)
Title |
---|
LAIRD P W ET AL: "The role of DNA methylation in cancer genetic and epigenetics.", ANNUAL REVIEW OF GENETICS. 1996, vol. 30, 1996, pages 441 - 464, XP002295974, ISSN: 0066-4197 * |
MODEL F ET AL: "FEATURE SELECTION FOR DNA METHYLATION BASED CANCER CLASSIFICATION", BIOINFORMATICS, OXFORD UNIVERSITY PRESS, OXFORD,, GB, vol. 17, no. SUPPL 1, June 2001 (2001-06-01), pages 157 - 164, XP001154594, ISSN: 1367-4803 * |
YAN P S ET AL: "CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 6, no. 4, April 2000 (2000-04-01), pages 1432 - 1438, XP002245955, ISSN: 1078-0432 * |
Also Published As
Publication number | Publication date |
---|---|
EP1502222A2 (en) | 2005-02-02 |
US20030036081A1 (en) | 2003-02-20 |
WO2003004696A2 (en) | 2003-01-16 |
JP2005516269A (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003004696A3 (en) | A distributed system for epigenetic based prediction of complex phenotypes | |
WO2001057274A3 (en) | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart | |
WO2002002807A3 (en) | Diagnosis of diseases associated with cell signalling | |
WO2001077377A3 (en) | Diagnosis of diseases associated with dna replication by assessing dna methylation | |
WO2001068911A8 (en) | Diagnosis of diseases associated with the cell cycle | |
WO2002080079A3 (en) | System and method for the detection of genetic interactions in complex trait diseases | |
HK1026003A1 (en) | Method of preparing a standard diagnostic gene transcript pattern. | |
AU2001247311A1 (en) | A system and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment | |
AU6796600A (en) | System, method, and article of manufacture for identifying an individual and managing an individual's health records | |
AU2001278840A1 (en) | Hydrogel biosensor and biosensor-based health alarm system | |
WO2005033334A3 (en) | Method for determining an active ingredient dosage | |
WO2000070340A3 (en) | Materials and methods relating to disease diagnosis | |
WO2001026029A3 (en) | Method and system for providing genotype clinical information over a computer network | |
WO2002063951A3 (en) | Human disease modeling using somatic gene transfer | |
WO2002036814A3 (en) | Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4 | |
EP2354228A3 (en) | Identification marker responsive to interferon therapy for renal cell cancer | |
WO2003023056A3 (en) | Specific markers for multiple sclerosis | |
WO2002036604A3 (en) | Diagnosis of diseases associated with the human c-mos gene | |
WO2004046382A3 (en) | Product and method | |
WO2002057499A3 (en) | Mdr1 variants and methods for their use | |
AU2003223033A8 (en) | System for point of care diagnosis and/or analysis | |
WO2002012554A3 (en) | Diagnosis of diseases which are associated with cd24 | |
AU2003276727A1 (en) | Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes | |
WO2003014879A3 (en) | System and method for identifying a genetic risk factor for a disease or pathology | |
WO2008088236A8 (en) | Method for genetically identifying a person according to the analysis of the single nucleotide polymorphism of a human genom by means of a oligonucleotide biological microchip (biochip) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002345042 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003510454 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002743199 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002743199 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002743199 Country of ref document: EP |